Market Snapshot
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 15.3 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The proteomics market studied was anticipated to grow with a CAGR of nearly 15.3% during the forecast period. Certain factors driving the market growth include rising demand for personalized medicine, increasing R&D expenditure and government funding for proteomics, and technological advancements.
These major drivers will continue to drive the biopharmaceutical industry's pursuit of blockbuster drugs and the recent technological advances in the studies of genes and proteins. Alliances are becoming increasingly important in this field because it is challenging for companies to find all the necessary expertise to cover all activities involved in proteomics. For example, many companies working with mass spectrometry and both the manufacturers and end-user labs are collaborating with protein chip-related companies. Increased demand for personalized medicines and increased R&D in proteomics are also driving factors for the market. However, the market is constrained by strict regulatory norms and the high cost of the instruments.
Scope of the Report
Proteomics is the study of protein structure and function. At the cellular level, proteomics deal with the topics, such as which proteins are expressed, when and where they are expressed, what their structures in both active and inactive states are, what roles they play in the life of the cell, and how they interact with other proteins and molecules.
| By Product & Services | ||||||||
| ||||||||
| Reagents | ||||||||
| Software and Services |
| By Application | |
| Clinical Diagnostics | |
| Drug Discovery | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Key Market Trends
Drug Discovery is Expected to Witness Healthy CAGR in Future
The identification of potential new drugs for the treatment of disease has been considered one of the most promising developments in the study of human genes and proteins. This depends on genome and proteome information for the identification of proteins, associated with a disease, which can then be used as targets for new drugs by computer software. Preclinical stages in the process of drug discovery need a multitude of genetic and biochemical assays in order to characterize the effects of drug candidates on cellular systems as well as model organisms. Almost every large pharmaceutical company now has proteomics-oriented biotech or academic partner or has started its own proteomics division. The general applications of proteomics in the drug industry include identification of efficacy and of toxicity biomarkers from readily accessible biological fluids, target identification and validation, and investigations into mechanisms of drug action or toxicity.
To understand key trends, Download Sample Report
North America dominates the Market and expected to do Same in the Forecast Period
In North America, antibody-drug conjugates and protein therapeutics play a significant role in the treatment and diagnosis of diseases. This is a continuously evolving field with extensive research on novel and innovative next-generation therapeutics. More than a hundred modified therapeutic proteins are approved for clinical use in the region. Hundreds of protein therapeutics are in clinical trials for the treatment of cancer, immune disorders, infections, age-related diseases, and many other conditions. Besides, research on proteomics is at the highest in countries like the United States.
To understand geography trends, Download Sample Report
Competitive Landscape
The global proteomics market is highly competitive and consists of a number of major players. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Inc., and Waters Corporation, among others, hold the substantial share in the proteomics market.
Recent Developments
In Feb 2021, Agilent Technologies Inc. launched Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.
In Dec 2020, Thermo Fisher Scientific, acquired Phitonex, Inc. Phitonex's product offering will enable Thermo Fisher to offer greater flow cytometry and imaging multiplexing capabilities to meet evolving customer needs in protein and cell analysis research.
Table of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Personalized Medicine
4.2.2 Increasing R&D Expenditure and Government Funding for Proteomics
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product & Services
5.1.1 Instrumentation Technology
5.1.1.1 Spectroscopy
5.1.1.2 Chromatography
5.1.1.3 Electrophoresis
5.1.1.4 Protein Microarrays
5.1.1.5 X-Ray Crystallography
5.1.1.6 Other Instrumentation Technologies
5.1.2 Reagents
5.1.3 Software and Services
5.2 By Application
5.2.1 Clinical Diagnostics
5.2.2 Drug Discovery
5.2.3 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies, Inc.
6.1.2 Bio-Rad Laboratories, Inc.
6.1.3 Bruker Corporation
6.1.4 Danaher Corporation
6.1.5 GE Healthcare
6.1.6 Merck KGaA
6.1.7 Promega Corporation
6.1.8 Thermo Fisher Scientific, Inc.
6.1.9 Waters Corporation
*List Not Exhaustive7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Proteomics Market market is studied from 2018 - 2026.
What is the growth rate of Proteomics Market?
The Proteomics Market is growing at a CAGR of 15.3% over the next 5 years.
Which region has highest growth rate in Proteomics Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Proteomics Market?
North America holds highest share in 2021.
Who are the key players in Proteomics Market?
Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare are the major companies operating in Proteomics Market.
